Literature DB >> 27873464

Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation.

G Einecke1, J Reeve2,3, P F Halloran2,3,4.   

Abstract

Because calcineurin inhibitor (CNI) immunosuppressive drugs induce arteriolar hyalinosis (ah) in kidney transplants, ah lesions can potentially provide information about drug exposure. We studied the relationship of ah lesions to findings and outcomes in 562 indication biopsies taken 3 days to 35 years after transplant. Prevalence of ah lesions increased with time of biopsy after transplant (TxBx). The ah scores correlated with arterial intimal thickening and atrophy-fibrosis but, unlike atrophy-fibrosis, did not increase until after 500 days because of a background of ah1 lesions in early biopsies reflecting donor aging. Correlation of ah scores with other features varied with TxBx-in early biopsies, donor age and related changes, and in very late biopsies, chronic antibody-mediated rejection and glomerulonephritis and associated lesions. After correction for TxBx, ah0 in intermediate time periods was associated with increased risk of T cell-mediated rejection and graft loss, probably because of underimmunosuppression and nonadherence. Thus, ah lesions in indication biopsies have multiple associations: donor age (early, usually ah1), chronic glomerular diseases (late, often ah2/3), and adequate exposure to CNIs at intermediate times. This threefold TxBx-dependent complexity must be considered when interpreting indication biopsies: ah lesions often indicate adequate CNI exposure, not toxicity, and unexpected ah0 should increase vigilance for nonadherence and underimmunosuppression.
© 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  basic (laboratory) research/science; biopsy; glomerular biology and disease; graft survival; kidney transplantation/nephrology; microarray/gene array

Mesh:

Year:  2017        PMID: 27873464     DOI: 10.1111/ajt.14136

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  Assessing rejection-related disease in kidney transplant biopsies based on archetypal analysis of molecular phenotypes.

Authors:  Jeff Reeve; Georg A Böhmig; Farsad Eskandary; Gunilla Einecke; Carmen Lefaucheur; Alexandre Loupy; Philip F Halloran
Journal:  JCI Insight       Date:  2017-06-15

2.  Transformation in Immunosuppression: Are We Ready for it?

Authors:  Amtul Aala; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2018-06-08       Impact factor: 10.121

3.  The Biology and Molecular Basis of Organ Transplant Rejection.

Authors:  Philip F Halloran; Gunilla Einecke; Majid L N Sikosana; Katelynn Madill-Thomsen
Journal:  Handb Exp Pharmacol       Date:  2022

4.  Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.

Authors:  Julio Pascual; Stefan P Berger; Oliver Witzke; Helio Tedesco; Shamkant Mulgaonkar; Yasir Qazi; Steven Chadban; Federico Oppenheimer; Claudia Sommerer; Rainer Oberbauer; Yoshihiko Watarai; Christophe Legendre; Franco Citterio; Mitchell Henry; Titte R Srinivas; Wen-Lin Luo; AnaMaria Marti; Peter Bernhardt; Flavio Vincenti
Journal:  J Am Soc Nephrol       Date:  2018-05-11       Impact factor: 10.121

5.  Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection.

Authors:  Gunilla Einecke; Jan Hinrich Bräsen; Nils Hanke; Hermann Haller; Anke Schwarz
Journal:  Case Rep Nephrol       Date:  2018-02-28

Review 6.  Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis.

Authors:  Tianyi Xia; Sang Zhu; Yan Wen; Shouhong Gao; Mingming Li; Xia Tao; Feng Zhang; Wansheng Chen
Journal:  Drug Des Devel Ther       Date:  2018-02-28       Impact factor: 4.162

7.  Nephrotoxicity of Calcineurin Inhibitors in Kidney Epithelial Cells is Independent of NFAT Signaling.

Authors:  Andrea Karolin; Geneviève Escher; Stefan Rudloff; Daniel Sidler
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

Review 8.  Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation.

Authors:  Rita Leal; Demetra Tsapepas; Russell J Crew; Geoffrey K Dube; Lloyd Ratner; Ibrahim Batal
Journal:  Kidney Int Rep       Date:  2017-10-27

9.  Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers After Renal Transplantation.

Authors:  Gerold Thölking; Nils Hendrik Gillhaus; Katharina Schütte-Nütgen; Hermann Pavenstädt; Raphael Koch; Barbara Suwelack; Stefan Reuter
Journal:  J Clin Med       Date:  2020-01-23       Impact factor: 4.241

Review 10.  Novel insights into non-HLA alloimmunity in kidney transplantation.

Authors:  Roman Reindl-Schwaighofer; Andreas Heinzel; Guido A Gualdoni; Laurent Mesnard; Frans H J Claas; Rainer Oberbauer
Journal:  Transpl Int       Date:  2019-11-28       Impact factor: 3.782

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.